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Implication for health policy/practice/research/medical education:
Acute kidney injury (AKI) is a common and serious condition, its diagnosis depends on serum creatinine, which is a delayed and 
unreliable indicator of AKI. In this study, postoperative creatinine, creatinine changes, urinary neutrophil gelatinase-associated 
lipocalin (NGAL) and urinary kidney injury molecule (KIM-1) were significantly higher in AKI patients than non-AKI patients. 
Serum creatinine was positively correlated with KIM-1 and NGAL. KIM-1 and NGAL had high ability to detect AKI. The 
availability of a suitable AKI biomarker could further revolutionize renal and critical care. However, further studies are needed 
for identification, validation, commercial development and acceptance of developed AKI biomarkers.
Please cite this paper as: Saeedi Ghaheh M, Mardani S, Malekpour A, Kadkhodaei Elyaderani F, Salehi Choliche F, Mortazavi 
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Introduction: Serum creatinine level is currently being used as an indicator to detect acute kidney 
injury (AKI) after cardiac surgery, which is delayed and unreliable.
Objectives: This study was conducted to determine the AKI in patients undergoing coronary 
artery bypass graft (CABG) surgery by measurement of urinary creatinine and plasma kidney 
injury molecule (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL).
Patients and Methods: In this cross-sectional study, 96 patients undergoing CABG were divided 
based on their serum creatinine level of the fourth day after procedure into two groups of AKI (an 
increase of creatinine more than 0.3 mg/dl or more than 150 % of its baseline level) and non-AKI. 
In both groups urinary KIM-1 and urinary NGAL were measured on the first day of surgery (first 
24 h). 
Results: No significant difference was observed in baseline creatinine between the two groups 
(P > 0.05). However postoperative serum creatinine, creatinine changes, urinary NGAL and KIM-
1 showed significant difference between the groups (P < 0.05). Serum creatinine was positively 
correlated with KIM-1 (r = 0.666, P < 0.001) and NGAL (r = 0.660, P < 0.001). KIM-1 and NGAL had 
high ability to detect AKI [area under the ROC (receiver operating characteristic) curve of 0.929 
and 0.838, respectively]. The NGAL at cut-off point of 97.4 had 86% sensitivity and 80% specificity 
and KIM-1 at cut-off point of 14.8 had 84% sensitivity and 89% specificity.
Conclusion: KIM-1 and NGAL had high ability to detect AKI. However, KIM-1 had higher 
detection ability than that of NGAL.
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Acute kidney injury (AKI) is one of the main 
complications observed after coronary artery bypass 
graft (CABG) surgery and re-vascularization of coronary 
arteries through the skin or percutaneous coronary 
intervention (PCI) with a prevalence of about 1%-30% 
depending on the study population (1). Higher age and 
the history of chronic kidney disease (CKD), are common 
risk factors for AKI in CABG and PCI. However, there 
are specific factors in any type of re-vascularization, 
for example, using cardiopulmonary bypass in CABG 
and contrast nephropathy in PCI which are the specific 
risk factors of AKI (2-4). In patients with AKI, not only 
the hospitalization stay and consequent postoperative 
complications increase, but also the risks for long-term 
side effects including CKD and end-stage renal disease 
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(ESRD) may increase (5). 
In AKI, early diagnosis is an essential key for successful 
treatment. Serum creatinine is currently used to diagnose 
renal dysfunction after surgery. However serum creatinine 
may not increase until a few days after the tubular injury, 
which results in a delay in the diagnosis and treatment 
of kidney damage (6,7). Therefore, the development 
of new AKI biomarkers is of great necessity for clinical 
and research purposes. An ideal biomarker should be 
non-invasive, fast and easy to perform and have a high 
sensitivity and specificity (8).
Neutrophil gelatinase-associated lipocalin (NGAL), also 
known as lipocalin 2 (LCN2) and oncogenes 24p3, is a 25-
kDa protein bound to neutrophils which is produced by 
neutrophils and a variety of epithelial cells. It is also found 
in variable levels in the stomach, colon, kidney, trachea, 
lung, uterus, prostate and salivary glands (9). In AKI, 
NGAL is excreted in large amounts in the blood and urine 
within two hours post-injury. NGAL levels in patients 
with AKI is associated with the severity and prognosis of 
the disease and can be used as an indicator for AKI (10). 
In this regard, clinical studies have shown that elevated 
NGAL levels have a high sensitivity and specificity for 
predicting AKI after surgery, especially in the first two 
hours after pediatric heart surgery (11). Previously, a 
significant relationship between increased urinary NGAL 
and AKI in adult patients undergoing heart surgery was 
shown (12).
Hepatitis A virus cellular receptor 1 (HAVcr-1), also 
known as T-cell immunoglobulin, mucin domain 1 
(TIM-1) and kidney injury molecule-1 (KIM-1), plays an 
important role in regulating cellular immunity, especially 
in host response to the viral infection. The KIM-1 or TIM-
1 marker is secreted from proximal tubular epithelial cells 
during ischemia and reduced blood flow to the kidney. 
This biomarker is secreted during the first 24-48 hours of 
insults which induced cell destruction, thereby it can be 
used as a primary biomarker in the diagnosis of AKI after 
heart surgery (13). Parikh et al showed that KIM-1 can be 
considered as an independent biomarker to indicate AKI 
after cardiac surgery and its associated side effects (14).
Objectives
The present study was aimed to determine urinary and 
plasma biomarkers in patients undergoing coronary artery 
bypass surgery and also to determine their diagnostic 
value.
Patients and Methods 
Study design
This study was a cross-sectional descriptive-analytical, 
conducted on 96 patients aged between 40 to 65 years 
who referred for CABG surgery to the hospitals of 
Shahrekord University of Medical Science, Shahrekord, 
Iran (2018). Patients with high risk obesity (body mass 
index; BMI ≥ 40 kg/m2), CKD, liver failure, drug abusers 
and coagulation problems were not included in the 
study. Additionally, patients who underwent heart-lung 
surgery without using a cardiopulmonary bypass pump or 
underwent simultaneous heart value and CABG surgeries 
were excluded from the study. The method of induction 
of anesthesia was the same in all patients and was based 
on the use of narcotic drugs and benzodiazepines as well 
as the use of muscle relaxants. To maintain anesthesia 
isoflurane and oxygen were used. Patient information 
such as age, gender, weight, height, risk factors including 
high blood pressure, diabetes mellitus, high fat, smoking 
and a positive family history of coronary artery disease 
were recorded in a special form. Before the procedure or 
surgery and after taking the signed consent form, patients’ 
serum creatinine level was measured to obtain its baseline 
level. Patients’ serum creatinine level was measured 
again after 4 days of surgery, then the individuals were 
divided into two groups based on the emerging situation 
of acute kidney injury; AKI (increasing 0.3 mg/dL from 
baseline creatinine or more than 150%) and non-AKI. In 
both groups, urinary levels of KIM-1 and NGAL, were 
measured on the first day of surgery (first 24 hours after 
surgery) too. 
Ethical issues
The research followed the tenets of the Declaration of 
Helsinki. The Ethics Committee of Shahrekord University 
of Medical Sciences approved this study. The institutional 
ethical committee at Shahrekord University of Medical 
Sciences approved all study protocols (IR.SKUMS.MSP.
REC.1397.176). Accordingly, written informed consent 
taken from all participants before any intervention. This 
study was the result of the internal medicine residential 
thesis of Maryam Saeedi at this university.
Data analysis
Data were analyzed by SPSS software. To describe the data, 
frequency indices and percentage were used for qualitative 
variables and mean ± standard deviation were used for 
quantitative variables. To test the differences between 
the studied groups, the independent t test (for approved 
data normality), Mann–Whitney U test (for rejected data 
normality) and chi-square test were used. The relationship 
between quantitative variables with normal distribution 
was determined using Pearson’s correlation coefficient 
since the Spearman’s correlation coefficient was used 
for qualitative variables or quantitative variables with no 
normal distribution. Moreover, ROC (receiver operating 
characteristic) curve was used for determining cutting 
point of the tests. In all tests, the significance level was 
considered at P < 0.05.
Results
In the present cross-sectional study, 96 patients undergoing 
CABG surgery were divided into two groups of AKI (45 
people, 46.9%) and non-AKI (51 people, 53.1%) patients 
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according to the serum creatinine levels of the fourth day 
after operation. The non-AKI group included 39 men 
(76.5%) and 12 women (23.5%) while the AKI group 
included 29 men (64.4%) and 16 women (35.6%). The two 
groups did not show any significant difference in terms 
of gender distribution (P > 0.05). Additionally, the mean 
age of patients in the AKI (50.04 ± 6.02 years) and non-
AKI (48.88 ± 4.52 years) groups did not show significant 
difference (P > 0.05). However, a significant difference 
was observed regarding BMI between two groups of AKI 
and non-AKI (30.25 ± 25.13 kg/m2 versus 23.91 ± 2.40 kg/
m2 respectively; P < 0.05).
As shown in Table 1, the baseline serum creatinine was 
not significantly different between AKI and non-AKI 
groups (P > 0.05), however the post-operative creatinine, 
NGAL and KIM-1 were significantly higher in AKI group 
compared with those of non-AKI group (P <0.05).
As shown in Table 2, serum creatinine of all patients had 
significantly positive relationship with KIM-1 (r = 0.666, 
P < 0.001) and NGAL (r = 0.66, P < 0.001). Furthermore, 
in patients with AKI, serum creatinine had significant 
positive correlations with KAM-1 (r= 0.448, P < 0.001) 
and NGAL (r = 0.544, P < 0.001). In contrast; in non-AKI 
patients, serum creatinine was not significantly correlated 
with KIM-1 or NGAL (P > 0.05).
As shown also in Table 3, the area under the ROC curve 
of the KIM-1 and NGAL factors, which indicate their 
diagnostic power was 0.929 and 0.838 respectively. The 
results indicated the high diagnostic power of both factors, 
although the KIM-1 showed greater diagnostic power 
compared to NGAL (based on a contractual classification 
system, the area under the curve of 0.9 -1 indicates the 
great power while area under the curve of 0.8-0.9 indicates 
good power). For NGAL at the cutting point of 97.4 ng/
dL the sensitivity of 86% and the specificity of 80 % were 
observed while the sensitivity of 84 % and specificity of 
89% were observed for the KIM-1 at cutting point of 14.8 
ng/dL.
Discussion
In the present cross-sectional study, 96 patients who 
underwent CABG surgery were divided into two groups 
of AKI and non- AKI (based on the post-operating 
serum creatinine of day forth). The two groups did not 
show any significant difference regarding gender and age 
distribution (P > 0.05). Moreover, BMI level was higher 
in AKI group (30.25 ± 25.13 kg/m2) than that of non-AKI 
group (23.91 ± 2.40 kg/m2; P < 0.05). Zou et al reported 
the risk of AKI in individuals with underweight, normal 
weight, overweight and obese who underwent cardiac 
surgery was respectively 29.9 %, 31 %, 36.5 % and 46 %, 
which showed a significant difference (P < 0.05) among 
them (15). Khreba et al reported that the mean age of 
patients who underwent CABG with AKI and without 
AKI were respectively 47.40 and 44.55 years. However, 
the difference was not significant (16). Likewise, Han et al 
studied the prevalence of AKI in patients who underwent 
CABG and found, patients with AKI were more likely to 
be older (17). 
In our study, the baseline creatinine was not significantly 
different between AKI and non-AKI groups (P > 0.05). 
Additionally, the post-operative serum creatinine was 
significantly higher in AKI group compared with that 
of non-AKI group (P < 0.05). Recently in the study 
conducted by Khreba et al, a significant increase in serum 
creatinine in AKI group 24 hours after surgery compared 
to that of non-AKI group was observed. None of their 
patients with AKI showed an absolute increase greater 
than 0.3 mg/dL in serum creatinine at baseline in the early 
hours after surgery (16). Han et al (17) and Mishra et al 
(11) also concluded that changes in serum creatinine were 
delayed, typically occurring 24 to 48 hours after the start 
of surgery.
In our study, the area below the ROC curve of urinary 
KIM-1 factor was 0.929, indicating its high diagnostic 
power in identifying AKI. For KIM-1 at the cutting point 
of 14.8 ng/dL, the sensitivity of 84% and the specificity 
of 89% were observed. Torregrosa et al showed the 
area below ROC curve for KIM-1 was 0.713 in patients 
under angiography and 0.716 in patients undergoing 
Table 1. Comparison of serum creatinine, NGAL and KIM-1 between AKI 
and non-AKI groups
Variable Non-AKI groupMean ± SD
AKI group
Mean ± SD P value
Baseline creatinine 
(mg/dL) 0.99 ±0.24 1.04 ± 0.27 0.335
Post-operative 
creatinine (mg/dL) 1.05 ± 0.24 1.82 ± 0.64 < 0.001
Creatinine level 
change (mg/dL) 0.059 ± 0.16 0.78 ± 0.57 < 0.001
Urinary NGAL (ng/dL) 78.54 ± 31.47 171.14 ±173.63 < 0.001
Urinary KIM-1 (ng/dL) 19.29 ± 5.88 6.07 ± 6.17 < 0.001
Table 2. The relationship between KIM-1 and NGAL based on spearman 
correlation test
Group KIM-1 NGAL
All patients (n = 96) R = 0.666P < 0.001**
R = 0.660
P < 0.001 **
Non-AKI (n = 61) R = 0.097P = 0.499
R = 0.232
P = 0.101
AKI (n = 45) R = 0.484P < 0.001**
R = 0.544
P < 0.001**
**The significant difference at P < 0.001 level.
Table 3. The area under ROC for KIM-1 and NGAL factors
Factor The area under ROC curve SE 95% CI
KIM-1 0.929 0.026 0.879 – 0.979
NGAL 0.838 0.035 0.814 – 0.952
SE, standard error; CI, confidence interval.
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cardiac surgery. In their study, the urinary KIM-I level 
was determined 12 hours after surgery (13). Recently, in 
the study by Khreba et al, the area under the ROC curve 
of the KIM-1 biomarker in patients who underwent 
CABG was 0.751. At the cutting point of 1.9, the KIM-1 
sensitivity for AKI detection was 48% and its specification 
was 94%. They measured the KIM-1 three hours after 
surgery (16). Previously, Han et al observed that the area 
below ROC for KIM-1 to predict AKI immediately and 
three hours after surgery was 0.68 and 0.65, respectively 
(17). Previously, Du et al studied a group of 252 children 
referring to emergency unit and found that 7.1 % of them 
had AKI since the predicting value of the KIM-1 for AKI 
was 0.73 (18). The differences appear to be most likely 
related to patient’s heterogeneity, the small populations 
under study and the difference in the post-operative 
sampling time. Additionally, the urinary concentration 
of KIM-1 may be affected by several factors such as 
sepsis, the administration of contrast medium and some 
common diseases including atherosclerosis, hypertension 
and diabetes (17). Our study compared to other studies 
showed a higher predicting value of KIM-1 to diagnose 
AKI, which is probably due to the measurement of KIM-1 
levels 24 hours after surgery.
Our study showed also that the area below the ROC 
curve for plasma NGAL, which indicating its diagnostic 
power was 0.838 which reveals its high diagnostic power. 
NGAL at the cutting point of 97.4 had the sensitivity of 
86% and a specificity of 80%. Torregrosa et al reported 
that the area under the ROC curve for urinary NGAL 
was 0.958 in patients under angiography and 0.916 in 
patients undergoing cardiac surgery while in their study 
NGAL levels in patients’ urine samples were determined 
12 hours after surgery (13). In a study by Parikh et al after 
multivariate adjustment, plasma NGAL which exceeded 
the fifth percentile was associated with 5-fold higher of 
AKI. The area below the ROC curve for NGAL was 0.750 
in patients with open heart surgery after six hours of 
surgery. Moreover, plasma NGAL had more predicting 
value than serum NGAL (19). In a previous meta-analysis 
conducted by Haase et al, the area below the ROC curve for 
the NGAL factor was 0.775 for cardiac surgery and 0.894 
for coronary angiography (20). Koyner et al reported the 
area below the ROC curve for plasma and urinary NGAL 
at 6 hours after surgery was 0.536 and 0.691 respectively 
(21). Accordingly in the study by Wagener et al, the area 
below the ROC curve for urinary NGAL factor was 0.573, 
0.603, 0.611 and 0.584 immediately after surgery, at 3, at 
18 and 24 hours after surgery respectively (8). In another 
study in 2009, the area below the ROC curve for plasma 
and urinary NGAL was 0.80 and 0.96 (22). The differences 
between the values reported in the different studies are 
due to the differences in sampling time, sample type and 
population studies.
In our study the area under the ROC curve of the KIM-
1 and NGAL factors which indicate their diagnostic power 
was 0.929 and 0.838 respectively. The results indicated the 
high diagnostic power of both factors although the KIM-
1 showed greater diagnostic power compared to NGAL. 
Han et al found that the area below the ROC curve for 
the KIM-1 factor to predict AKI was higher than NGAL 
immediately and three hours postoperatively (0.680 
and 650 compared to 0.590 and 650). A combination of 
biomarkers has increased sensitivity to early detection of 
AKI compared to the application of single biomarkers (17). 
In a study conducted by Torregrosa et al, the area below 
the ROC curve for NGAL and KIM-1 was 0.916 and 0.716 
in patients undergoing cardiac surgery, indicating the 
greater predicting value of NGAL. In their study NGAL 
levels in urine samples of patients were determined 12 
hours after surgery (13). In another similar study, the area 
below the ROC curve for NGAL and KIM-1 in children 
referred to the emergency unit was respectively 0.66 and 
0.61, indicating the higher predicting value of NGAL (18). 
As can be seen, contradictory results have been reported 
regarding the diagnostic accuracy of NGAL and KIM-
1. Therefore further studies are needed to compare the 
diagnostic accuracy of the above two factors at different 
Figure 1. ROC curve of KIM-1 (A) and NGAL (B).
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times of sampling as well as their effectiveness.
Despite much efforts conducted to identify AKI the 
predictive value of biomarkers, the true usefulness 
of different AKI biomarkers has not yet been fully 
elucidated. Finding of an ideal biomarker for the early 
detection of AKI is still under consideration, while several 
questions concerning the best biomarker/combination of 
biomarkers, the cutting point with the best sensitivity and 
specificity, the performance of biomarkers in different 
populations and different clinical environments, the 
determination of biomarkers in blood or urine, the best 
sampling time and the ability to distinguish between 
functional and structural AKI are existed (16). Our study 
showed KIM-1 and NGAL biomarkers had a very good 
diagnostic power in identifying AKI between 24 hours 
after surgery in patients undergoing CABG surgery. 
Conclusion
According to our results, patients with AKI had higher 
levels of serum creatinine, urinary NGAL and KIM-1 
compared to non-suspected patients. Serum creatinine 
had also a significant positive relationship with urinary 
KIM-1 and NGAL. Urinary KIM-1 and NGAL factors 
had a high predicting value in AKI detection (the area 
below the ROC curve was 0.929 and 0.838, respectively). 
NGAL had a sensitivity of 86% and specificity of 80 % 
at the cutting point of 97.4 and KIM-1 had a sensitivity 
of 84 % and specificity of 89 % at a cutting point of 14.8. 
Generally, it was observed that in patients undergoing 
CABG surgery urinary KIM-1 and NGAL biomarkers 
had a proper diagnostic power in identifying AKI between 
12-24 hours after surgery. Using these biomarkers can 
provide faster identification of AKI, which consequently 
leads to suitable prevention and therapeutic strategies.
Limitations of the study
The number of patients in the AKI group was relatively 
small and further studies with a larger population are 
required. It is suggested that the tests be measured with 
few hours intervals to determine the best time having the 
most sensitivity and specificity, which was not possible in 
our study due to our finance constraints.
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